Antibiotics Treatment in Helicobacter pylori Infection
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 3932
Special Issue Editors
Interests: psychiatric diseases; adherence; pharmacy practice research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The results of previously published research report that Helicobacter pylori infections have been reported in 50% of the general population, and even in 80% of people in less-developed countries. These proportions are high, and especially disturbing if we have in mind that this infection leads to gastric inflammation and consequently to peptic ulcer disease or even gastric carcinoma. Therefore, appropriate antibiotic treatment of Helicobacter pylori infection is crucial not only for gastric complications prevention in patients but also for the management of possible microbial drug resistance, recognized as an emerging public health care concern. Therefore, we aim to gather valuable data on infection management, antibiotic adverse drug reaction reports and initiatives to raise awareness of antibiotic resistance.
Dr. Josipa Bukić
Dr. Filipa F Vale
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Helicobacter
- antibiotics
- adverse drug reaction
- microbial drug resistance
- antimicrobial stewardship
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
